Esther Pomares

647 total citations
30 papers, 489 citations indexed

About

Esther Pomares is a scholar working on Molecular Biology, Ophthalmology and Cell Biology. According to data from OpenAlex, Esther Pomares has authored 30 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 12 papers in Ophthalmology and 7 papers in Cell Biology. Recurrent topics in Esther Pomares's work include Retinal Development and Disorders (27 papers), Retinal Diseases and Treatments (10 papers) and RNA regulation and disease (6 papers). Esther Pomares is often cited by papers focused on Retinal Development and Disorders (27 papers), Retinal Diseases and Treatments (10 papers) and RNA regulation and disease (6 papers). Esther Pomares collaborates with scholars based in Spain and United States. Esther Pomares's co-authors include Roser Gonzàlez‐Duarte, Gemma Marfany, Rafael Navarro, Anniken Burés‐Jelstrup, Borja Corcóstegui, Jon Permanyer, Sara Cervantes, Carlos A. Saura, Ángel Carracedo and Marı́a Brión and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Esther Pomares

30 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esther Pomares Spain 14 413 176 89 70 61 30 489
Avigail Beryozkin Israel 13 512 1.2× 224 1.3× 158 1.8× 90 1.3× 64 1.0× 21 569
Janneke J.C. van Lith-Verhoeven Netherlands 9 383 0.9× 289 1.6× 53 0.6× 86 1.2× 46 0.8× 12 483
Carmela Ziviello Italy 11 455 1.1× 238 1.4× 101 1.1× 45 0.6× 80 1.3× 15 545
Christelle Michiels France 14 532 1.3× 279 1.6× 74 0.8× 57 0.8× 203 3.3× 28 641
Marie Burstedt Sweden 15 463 1.1× 290 1.6× 50 0.6× 75 1.1× 73 1.2× 32 545
Hee-Sheung Lee United States 12 353 0.9× 71 0.4× 75 0.8× 65 0.9× 57 0.9× 14 463
Michael W. Stuck United States 15 491 1.2× 111 0.6× 149 1.7× 192 2.7× 100 1.6× 22 547
Ram Fridlich France 7 419 1.0× 140 0.8× 46 0.5× 33 0.5× 148 2.4× 8 502
Suzanne Broadgate United Kingdom 10 351 0.8× 177 1.0× 87 1.0× 57 0.8× 49 0.8× 25 423
Julie E. Smith United States 9 524 1.3× 280 1.6× 65 0.7× 98 1.4× 161 2.6× 10 623

Countries citing papers authored by Esther Pomares

Since Specialization
Citations

This map shows the geographic impact of Esther Pomares's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Pomares with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Pomares more than expected).

Fields of papers citing papers by Esther Pomares

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Pomares. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Pomares. The network helps show where Esther Pomares may publish in the future.

Co-authorship network of co-authors of Esther Pomares

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Pomares. A scholar is included among the top collaborators of Esther Pomares based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Pomares. Esther Pomares is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pomares, Esther, et al.. (2025). Rescue of the disease-associated phenotype in CRISPR-corrected hiPSCs as a therapeutic approach for inherited retinal dystrophies. Molecular Therapy — Nucleic Acids. 36(1). 102482–102482. 1 indexed citations
2.
Pomares, Esther, et al.. (2025). Endoplasmic reticulum stress and rhodopsin accumulation in an organoid model of Retinitis Pigmentosa carrying a RHO pathogenic variant. Stem Cell Research & Therapy. 16(1). 71–71. 1 indexed citations
3.
Pomares, Esther, et al.. (2023). High-Efficiency CRISPR/Cas9-Mediated Correction of a Homozygous Mutation in Achromatopsia-Patient-Derived iPSCs. International Journal of Molecular Sciences. 24(4). 3655–3655. 5 indexed citations
4.
Pomares, Esther, et al.. (2023). Efficient correction of ABCA4 variants by CRISPR-Cas9 in hiPSCs derived from Stargardt disease patients. Molecular Therapy — Nucleic Acids. 32. 64–79. 15 indexed citations
5.
Navarro, Rafael, et al.. (2022). Impaired Bestrophin Channel Activity in an iPSC-RPE Model of Best Vitelliform Macular Dystrophy (BVMD) from an Early Onset Patient Carrying the P77S Dominant Mutation. International Journal of Molecular Sciences. 23(13). 7432–7432. 5 indexed citations
7.
Navarro, Rafael, et al.. (2020). Identification of a novel homozygous ARSG mutation as the second cause of Usher syndrome type 4. American Journal of Ophthalmology Case Reports. 19. 100736–100736. 24 indexed citations
9.
Burés‐Jelstrup, Anniken, et al.. (2019). Establishment of an induced pluripotent stem cell line (FRIMOi005-A) derived from a retinitis pigmentosa patient carrying a dominant mutation in RHO gene. Stem Cell Research. 38. 101468–101468. 5 indexed citations
10.
Burés‐Jelstrup, Anniken, et al.. (2019). Characterization of the cone-rod dystrophy retinal phenotype caused by novel homozygous DRAM2 mutations. Experimental Eye Research. 187. 107752–107752. 7 indexed citations
11.
Patel, Achchhe, Anniken Burés‐Jelstrup, Borja Corcóstegui, et al.. (2019). Generation of two iPS cell lines (FRIMOi003-A and FRIMOi004-A) derived from Stargardt patients carrying ABCA4 compound heterozygous mutations. Stem Cell Research. 36. 101389–101389. 12 indexed citations
12.
Navarro, Rafael, et al.. (2019). Expanding the retinal phenotype of RP1: from retinitis pigmentosa to a novel and singular macular dystrophy. British Journal of Ophthalmology. 104(2). 173–181. 15 indexed citations
14.
Patel, Achchhe, Borja Corcóstegui, Stanley Chang, et al.. (2019). Generation of an induced pluripotent stem cell line (FRIMOi002-A) from a retinitis pigmentosa patient carrying compound heterozygous mutations in USH2A gene. Stem Cell Research. 35. 101386–101386. 7 indexed citations
15.
Navarro, Rafael, et al.. (2017). Whole exome sequencing using Ion Proton system enables reliable genetic diagnosis of inherited retinal dystrophies. Scientific Reports. 7(1). 42078–42078. 47 indexed citations
16.
Castro‐Miró, Marta de, Esther Pomares, Laura Lorés‐Motta, et al.. (2014). Combined Genetic and High-Throughput Strategies for Molecular Diagnosis of Inherited Retinal Dystrophies. PLoS ONE. 9(2). e88410–e88410. 27 indexed citations
17.
Pomares, Esther, Gemma Marfany, & Roser Gonzàlez‐Duarte. (2011). High-Throughput Approaches for the Genetic Diagnosis of Retinal Dystrophies. Advances in experimental medicine and biology. 723. 329–335. 1 indexed citations
18.
Pomares, Esther, et al.. (2009). An Intronic Mutation in RP2 Causes Semi-Dominant X-Linked Retinitis Pigmentosa. Investigative Ophthalmology & Visual Science. 50(13). 2299–2299. 1 indexed citations
19.
Brea‐Fernández, Alejandro, Esther Pomares, Marı́a Brión, et al.. (2008). Novel splice donor site mutation in MERTK gene associated with retinitis pigmentosa. British Journal of Ophthalmology. 92(10). 1419–1423. 28 indexed citations
20.
Pomares, Esther, Gemma Marfany, Marı́a Brión, Ángel Carracedo, & Roser Gonzàlez‐Duarte. (2007). Novel high-throughput SNP genotyping cosegregation analysis for genetic diagnosis of autosomal recessive retinitis pigmentosa and Leber congenital amaurosis. Human Mutation. 28(5). 511–516. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026